Thursday, December 31, 2015 11:41:55 AM
Recent CMRX News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 09:20:48 PM
- Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting • GlobeNewswire Inc. • 11/11/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 12:28:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 12:10:26 PM
- Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 11/07/2024 12:00:00 PM
- Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024 • GlobeNewswire Inc. • 11/01/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2024 12:00:11 AM
- Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 10/18/2024 08:31:09 PM
- Chimerix to Present at H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2024 11:00:00 AM
- Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/30/2024 08:05:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/13/2024 08:05:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 11:22:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 11:03:39 AM
- Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 08/13/2024 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/09/2024 05:26:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 04:01:08 PM
- Chimerix to Report Second Quarter 2024 Financial Results and Provide an Operational Update on August 13, 2024 • GlobeNewswire Inc. • 08/06/2024 11:00:00 AM
- Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/05/2024 08:05:00 PM
- Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/30/2024 11:00:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/06/2024 04:15:24 AM
- Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024 • GlobeNewswire Inc. • 04/24/2024 11:00:00 AM
- Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/16/2024 08:05:00 PM
- Chimerix Appoints Marc D. Kozin to Board of Directors • GlobeNewswire Inc. • 03/21/2024 11:00:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/29/2024 02:20:57 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM